Prevalence of thromboembolic events and status of prophylactic anticoagulant therapy in hospitalized patients with COVID-19 in Japan.
Fujiwara S, Nakajima M, Kaszynski RH, Fukushima K, Tanaka M, Yajima K, Kobayashi T, Sekiya N, Yamamoto Y, Miwa M, Ishihata A, Yamauchi Y, Yamamoto K, Goto H, Imamura A.
Fujiwara S, et al. Among authors: tanaka m.
J Infect Chemother. 2021 Jun;27(6):869-875. doi: 10.1016/j.jiac.2021.02.019. Epub 2021 Feb 19.
J Infect Chemother. 2021.
PMID: 33663933
Free PMC article.